Yoav Amitai – CEO – Elsight's (ASX:ELS) Halo provides connectivity and delivers absolute connection confidence for drones and other unmanned systems.
Copyright 2023 – Finance News Network
Source: Finance News Network
16 Sep 2019 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams discusses the company’s high-grade exploration results from its northern NSW project, plus how it’s poised to benefit from the rise of ‘critical minerals’ designation.
Read More10 Mar 2025 - CEO Marc Voigt on Clinical Trials, Regulatory Milestones, and Market Growth
Read More24 Apr 2020 - Telix Pharmaceuticals (ASX:TLX), Chief Business Officer, David Cade talks about its prostate cancer imaging product, diagnostic and therapeutic products, partners and key priorities for 2020.
Read More30 Mar 2020 - XTEK Limited (ASX:XTE) Managing Director Philippe Odouard talks 1H20 results, the company's front-line products for the Australian Defence Force and police forces, US strategy and outlook.
Read More16 Apr 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook talks about the growing demand for digital payments and the opportunities this presents for the company.
Read More09 Sep 2024 - ABx Group Limited (ASX:ABX) Managing Director and CEO Dr Mark Cooksey discusses the significance of the company's memorandum of understanding with Ucore Rare Metals.
Read More27 Apr 2022 - Acorn Capital Investment Fund (ASX:ACQ) Portfolio Manager Rick Squire discusses key factors behind commodity demand and which commodities to keep an eye on.
Read More31 Jan 2020 - Los Cerros Limited (ASX:LCL) Managing Director, Jason Stirbinskis, talks about the company's gold projects in Colombia, the potential for high grade porphyry despots and plans to advance drilling at its Chuscal target.
Read More21 Sep 2023 - Ken Aitken - Managing Director - Metgasco (ASX:MEL) is a petroleum (oil and gas) exploration and production company, listed on the Australian Securities Exchange.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More
